Comparison of the Acute Rejection Incidence Rate in Spousal Donor Transplantation Before and After Anti-CD20 Antibody (Rituximab) Protocol as Desensitization Therapy

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 1, 2011, Pages 89-97

  Hirai, Toshihito ^a,b   Ishida, Hideki ^a   Toki, Daisuke ^a   Miyauchi, Yuuki ^a   Kohei, Naoki ^a   Iida, Shouichi ^a   Tokita, Daisuke ^a   Shimizu, Tomokazu ^a   Shirakawa, Hiroki ^a   Omoto, Kazuya ^a   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Anti CD20 antibody; Desensitization; Spousal donor transplantation; T cell mediated rejection

Indexed keywords

BASILIXIMAB; CD20 ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORTHOCLONE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CONTROLLED STUDY; DESENSITIZATION; DRUG DOSE TITRATION; FEMALE; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SPOUSE; T LYMPHOCYTE;

ACUTE DISEASE; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; SPOUSES; YOUNG ADULT;

EID: 79251563787     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00856.x     Document Type: Article

References (31)

1. Ishikawa N, Tanabe K, Tokumoto T etal. Long-term results of living unrelated renal transplantation. Transplant Proc 1999;31:2856.
2. Fuller TF, Feng S, Brennan TV, Tomlanovich S, Bostrom A, Freise CE. Increased rejection in living unrelated vs. living related kidney transplants does not affect short-term function and survival. Transplantation 2004;78:1030.
3. Long DG, Vernon WB, Yanover MJ. Increased acute rejection episodes among recipients of living unrelated donor compared with cadaver and living related donor renal transplants. Transplant Proc 2002;34:1673.
4. Kwon OJ, Kim YH, Ahn BK, Kang CM, Kwak JY. Long-term graft outcome of living donor renal transplantation: single center experience. Transplant Proc 2005;37:690.
5. Gheith O, Sabry A, El-Baset SA etal. Study of the effect of donor source on graft and patient survival in pediatric renal transplant recipients. Pediatr Nephrol 2008;23:2075.
6. Rosenberg JC, Jones B, Oh H. Accelerated rejection following offspring-to-mother and husband-to-wife transplants. Clin Transplant 2004;18:729.
7. Ghafari A. Offspring-to-mother and husband-to-wife renal transplantation: a single-center experience. Transplant Proc 2008;40:140.
8. Burlingham WJ, Grailer AP, Heisey DM etal. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998;339:1657.
9. Tanabe K. Double-filtration plasmapheresis. Transplantation 2007;84(12 Suppl):S30.
10. Ishida H, Miyamoto N, Shirakawa H etal. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 2007;7:825.
11. Tanabe K, Ishida H, Shimizu T, Omoto K, Shirakawa H, Tokumoto T. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Contrib Nephrol 2009;162:61.
12. Ishida H, Tanabe K, Furusawa M etal. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients-examination of 238 cases of renal transplantation. Transpl Int 2005;18:163.
13. Tanabe K, Tokumoto T, Ishida H etal. Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid. Transplant Proc 2004;36:2175.
14. Toki D, Ishida H, Setoguchi K etal. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant 2009;9:567.
15. Agishi T, Kaneko I, Hasuo Y etal. Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs 1980;26:406.
16. Reding R, Squifflet JP, Pirson Y etal. Living-related and unrelated donor kidney transplantation: comparison between ABO-compatible and incompatible grafts. Transplant Proc 1987;19(1 Pt 2):1511.
17. Sawada T, Fuchinoue S, Kawase T, Kubota K, Teraoka S. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation. Clin Transplant 2004;18:254.
18. Montgomery RA, Zachary AA, Racusen LC etal. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000;70:887.
19. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S. A comparison of plasmapheresis vs. high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006;6:346.
20. Haririan A, Nogueira J, Kukuruga D etal. Positive cross-match living donor kidney transplantation: longer-term outcomes. Am J Transplant 2009;9:536.
21. Sonnenday CJ, Warren DS, Cooper M etal. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004;4:1315.
22. Tyden G, Genberg H, Tollemar J etal. A randomized, double-blind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation. Transplantation 2009;87:1325.
23. Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000;11:565.
24. Matas AJ, Payne WD, Sutherland DE etal. 2, 500 living donor kidney transplants: a single-center experience. Ann Surg 2001;234:149.
25. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995;333:333.
26. Lim WH, Chang SH, Coates PT, McDonald SP. Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration rates. Transplantation 2007;84:972.
27. Debska-Sslizien A, Jankowska MM, Wolyniec W etal. A single-center experience of renal transplantation in elderly patients: a paired-kidney analysis. Transplantation 2007;83:1188.
28. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000;164:3596.
29. Hawiger D, Inaba K, Dorsett Y etal. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001;194:769.
30. Tyden G, Mjornstedt L, Ekberg H. More on B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med 2009;361:1214.
31. Clatworthy MR, Watson CJ, Plotnek G etal. B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med 2009;360:2683.